If you’re exploring MS care in North Carolina, you have access to specialized centers across the state, from major programs like Atrium Health Neurosciences Institute and Duke Neurological Disorders Clinic to regional centers such as Charlotte Center for Multiple Sclerosis and Raleigh Neurology Associates. Use this page to compare services, provider experience, and location so you can find a center that fits your needs and preferences.
11 MS treatment centers19 active clinical trialsTop programs: Atrium Health, Duke18 providers with Medicare prescribing data
Center types in North Carolina
Regional Neurology Group (5)
Dedicated MS Practice (3)
Academic MS Center (3)
Filter by type:
45% of MS centers in North Carolina are classified as Regional Neurology Group facilities.
Centers with Most Active Trials in North Carolina
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in North Carolina
1. Atrium Health Neurosciences Institute6 providers
2. Wake Forest Baptist Health MS Center6 providers
3. Duke Neurological Disorders Clinic3 providers
MS Care by City
Active MS clinical trials in North Carolina
See all 23 MS trials in North Carolina →ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Chapel Hill · Charlotte
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Chapel Hill · Charlotte · +1
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Charlotte · Raleigh
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Raleigh
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Charlotte · Raleigh
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Asheville · Charlotte · +3
ActivePhase 3
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
Winston-Salem
ActivePhase 3
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Charlotte · Charlotte · +2




